首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and biological evaluation of 2-indolinone derivatives as potential antitumor agents.
【24h】

Synthesis and biological evaluation of 2-indolinone derivatives as potential antitumor agents.

机译:作为潜在抗肿瘤药的2-吲哚满酮衍生物的合成和生物学评估。

获取原文
获取原文并翻译 | 示例
           

摘要

Three series of 3-substituted-indolin-2-ones and azaindolin-2-ones have been synthesized and showed potential antiproliferative activity to cancer cell lines. The inhibition activities on VEGF-induced VEGFR phosphorylation were observed for selected 2-indolinones. Among the compounds synthesized, 5-fluoroindolin-2-one derivative 23 with a pyridone unit showed the most significant enzymatic and cellular activities. Flow cytometric analysis indicates that 23 plays a role in suppressing HCT-116 cell proliferation via G1 phase arrest and apoptosis in a dose dependent manner. The binding mode of compound 23 complexed with VEGFR-2 was predicted using FlexX algorithm. Described here are the chemistry and biological testing for these series which will guide the design and optimization of novel 2-indolione antitumor agents.
机译:已经合成了三个系列的3-取代的吲哚-2-酮和氮杂吲哚-2-酮,它们显示出对癌细胞系潜在的抗增殖活性。对于选定的2-吲哚满酮,观察到了对VEGF诱导的VEGFR磷酸化的抑制活性。在合成的化合物中,具有吡啶酮单元的5-氟吲哚-2-酮衍生物23显示出最显着的酶和细胞活性。流式细胞仪分析表明23在剂量依赖性的G1期阻滞和凋亡中抑制HCT-116细胞增殖。使用FlexX算法预测与VEGFR-2复合的化合物23的结合模式。这里描述的是这些系列的化学和生物学测试,它们将指导新型2-吲哚酮抗肿瘤剂的设计和优化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号